Physiologically Achievable Concentration of 2-Deoxy-D-Glucose Stimulates IFN-γ Secretion in Activated T Cells In Vitro
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910384 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jernej Repas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biophysics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Interferon-gamma, Deoxyglucose, Lymphocyte Activation, T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research and Innovation Agency, Austrian Science Fund, Slovenian Research and Innovation Agency Young.
Abstract (Originalsprache)
2-deoxy-D-glucose (2DG) is a glycolysis and protein N-glycosylation inhibitor with promising anti-tumor and immunomodulatory effects. However, 2DG can also suppress T cell function, including IFN-γ secretion. Few human T cell studies have studied low-dose 2DG, which can increase IFN-γ in a Jurkat clone. We therefore investigated 2DG’s effect on IFN-γ in activated human T cells from PBMCs, with 2DG treatment commenced either concurrently with activation or 48 h after activation. Concurrent 2DG treatment decreased IFN-γ secretion in a dose-dependent manner. However, 2DG treatment of pre-activated T cells had a hormetic effect on IFN-γ, with 0.15–0.6 mM 2DG (achievable in vivo) increasing and >2.4 mM 2DG reducing its secretion. In contrast, IL-2 levels declined monotonously with increasing 2DG concentration. Lower 2DG concentrations reduced PD-1 and increased CD69 expression regardless of treatment timing. The absence of increased T-bet or Eomes expression or IFNG transcription suggests another downstream mechanism. 2DG dose-dependently induced the unfolded protein response, suggesting a possible role in increased IFN-γ secretion, possibly by increasing the ER folding capacity for IFN-γ via increased chaperone expression. Overall, low-dose, short-term 2DG exposure could potentially improve the T cell anti-tumor response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biophysics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Trials Unit for Interdisciplinary Metabolic Medicine, Division of Endocrinology and Diabetology, Medical University Graz, 8010 Graz, Austria.
- Clinical Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
- Group for Nano- and Biotechnological Applications, Faculty of Electrical Engineering, University of Ljubljana, 1000 Ljubljana, Slovenia.
ORCID-Profile: Andreja Nataša Kopitar, Harald Sourij, Andrej Janež, Mojca Pavlin
Förderung
- Slovenian Research and Innovation Agency
- Austrian Science Fund
- Slovenian Research and Innovation Agency Young
- Slovenian Research Agency
Zitieren
APA
Repas, J., Frlic, T., Snedec, T., Kopitar, A. N., Sourij, H., Janež, A., & Pavlin, M. (2024). Physiologically Achievable Concentration of 2-Deoxy-D-Glucose Stimulates IFN-γ Secretion in Activated T Cells In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910384
Vancouver
Repas J, Frlic T, Snedec T, Kopitar AN, Sourij H, Janež A, et al. Physiologically Achievable Concentration of 2-Deoxy-D-Glucose Stimulates IFN-γ Secretion in Activated T Cells In Vitro. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910384
BibTeX
@article{Repas2024,
author = {Repas, Jernej and Frlic, Tjaša and Snedec, Tadeja and Kopitar, Andreja Nataša and Sourij, Harald and Janež, Andrej and Pavlin, Mojca},
title = {Physiologically Achievable Concentration of 2-Deoxy-D-Glucose Stimulates IFN-γ Secretion in Activated T Cells In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910384}
}
EUVIMED